#Immunotherapy

Shematologist, MD

acweyand

Did you know that immunotherapy for malignancy dates back to 1891?Immunotherapy works by stimulating your immune system to attack cancer cells. After losing a patient to sarcoma, Dr Coley found

Dr. Dave Stukus

AllergyKidsDoc

Topic 5 in new 2020 asthma guidelines addresses use of allergen immunotherapy specifically for treatment of asthma. This includes allergy shots (subcutaneous immunotherapy or SCIT) and sublingual drops (SLIT).Full guidelines

Joshua Bauml, MD

Jbauml

Tonight at #WCLC20 we saw a RCT presented by Dr Lai on behalf of co-authors looking at immunotherapy in patients with EGFR+ NSCLC. Patients had disease that progressed on at

Henry Scowcroft

oh_henry

THREAD. Just over 4 years ago, I sat in a pub with some @CR_UK colleagues, all staring at our phones, waiting to see if a research story we'd worked on

Bruce Levine

BLLPHD

#OTD celebrating 10 years since 1st CAR19 #Tcell infusion @PennMedicine We thank all patient #Heroes for volunteering to advance #cancer #Immunotherapy https://www.nytimes.com/2011/09/13/health/13gene.html Since this has blown up, creating

The Pittet Lab

PittetLab

Happy to share our latest work on tumor-infiltrating dendritic cells (DC)! https://doi.org/10.1084/jem.20200264 We know these cells can play key antitumor functions, but they require more attention and could become important

Amy Wisdom

AmyWisdom8

Excited to share that our paper is out today in @NatureComms https://www.nature.com/articles/s41467-020-19917-0. A great collaboration from @DKirschMDPhD @YvonneMowery @DukeRadOnc @DukeCancer and @Barzin_@max_diehn @StanfordCancer examining

Sri Krishna

tellkrish

With @franklowery our new study on attributes of T cells that contribute to successful cell therapy in cancer patients in @ScienceMagazine today w/ colleagues @slgoff_SB, @NCI_CCR_SB @theNCI a TL;DR thread

Paul Bröckelmann

BroeckelmannPJ

Excited to share updated data of the GHSG phase II NIVAHL trial investigating sequential and concomitant Nivo + AVD 1st-line treatment in early-stage unfavorable #Hodgkin lymphoma at @ASH_hematology: https://bit.ly/2LgW0g5

Eli Van Allen

VanAllenLab

Interested to see how the forthcoming data behind the ‘TMB > 10 in all cancer types’ approval addresses a few key issues, having spent a long time thinking about this

deej

deejitarian

Why is Pfizer allowed to call this treatment a “vaccine”? It’s a cellular immunotherapy. It interacts directly with a person’s genetic material at the intracellular level, unlike traditional vaccines, con’t.

Jason Sheltzer

JSheltzer

An amazing *randomized trial* on Twitter+academia:112 papers were randomly chosen to be shared on twitter by a group with ~58k followers or to not be shared. Papers that were tweeted

Phelps Hospital

phelpshospital

#PhelpsHospital #NorthwellHealth #ChatWithPhelps #BreastCancer #oncology Some common treatments for breast cancer include chemotherapy, immunotherapy, radiation or hormone therapy, and surgery. The individual treatment plan depends on the t

Delgoffe Lab

DelgoffeLab

At long last, I get to share publication of a project (out today in @Nature) on which I started my lab at @UPMCHillmanCC and @PittTweet in 2014. In it, we

Aaron Ring

aaronmring

Our lab's first paper (https://rdcu.be/b49xK ) is now out at @nature. We found that the cytokine IL-18 can drive potent anti-tumor activity from the innate and adaptive immune system, but that

NatResearchCancer

NatResCancer

Looking to read something inspirational and awesome over the holidays? The @NatResCancer editors have you covered with our new Milestones in Cancer research timeline! There’s something here for everyone! (1/n)https://go.nature.com/3n0h3RQ

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.